Similarly, combined 5-aza-dC and TSA (trichostatin A) treatments restored GL1 (GABARAPL1, GABA type A receptor-associated protein like 1) expression in breast cancer cell models [11]. The gene discussed is GABARAPL1; the disease is breast cancer.